IL115495A0 - Use and composition of an anti-sexually transmitted disease formulation - Google Patents

Use and composition of an anti-sexually transmitted disease formulation

Info

Publication number
IL115495A0
IL115495A0 IL11549595A IL11549595A IL115495A0 IL 115495 A0 IL115495 A0 IL 115495A0 IL 11549595 A IL11549595 A IL 11549595A IL 11549595 A IL11549595 A IL 11549595A IL 115495 A0 IL115495 A0 IL 115495A0
Authority
IL
Israel
Prior art keywords
composition
stds
infectant
std
bioadhesive
Prior art date
Application number
IL11549595A
Other languages
English (en)
Original Assignee
Bologna William J
Levine Howard L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bologna William J, Levine Howard L filed Critical Bologna William J
Publication of IL115495A0 publication Critical patent/IL115495A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/14Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11549595A 1994-10-07 1995-10-02 Use and composition of an anti-sexually transmitted disease formulation IL115495A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
IL115495A0 true IL115495A0 (en) 1996-01-19

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11549595A IL115495A0 (en) 1994-10-07 1995-10-02 Use and composition of an anti-sexually transmitted disease formulation

Country Status (24)

Country Link
US (2) US5667492A (es)
EP (1) EP0784466B1 (es)
JP (1) JPH10507178A (es)
KR (1) KR970705976A (es)
AT (1) ATE213623T1 (es)
AU (1) AU704836B2 (es)
BR (1) BR9509280A (es)
CA (1) CA2201872A1 (es)
CO (1) CO4480018A1 (es)
DE (1) DE69525634T2 (es)
DK (1) DK0784466T3 (es)
ES (1) ES2173203T3 (es)
FI (1) FI971440A (es)
HU (1) HUT77527A (es)
IL (1) IL115495A0 (es)
MA (1) MA23687A1 (es)
MX (1) MX9504245A (es)
NO (1) NO971491L (es)
NZ (1) NZ295947A (es)
PE (1) PE46996A1 (es)
PT (1) PT784466E (es)
RU (1) RU2157184C2 (es)
WO (1) WO1996010989A1 (es)
ZA (1) ZA958434B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
KR20010012464A (ko) * 1997-05-12 2001-02-15 세이지 파마슈티칼스, 인크. 화상 치료 및 감염 방지를 위한 국소 분무
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
EP1356806A1 (en) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
KR20010083057A (ko) 1998-06-19 2001-08-31 추후제출 항-감염 및 피임성을 갖는 의료 장치
WO1999066900A2 (de) * 1998-06-23 1999-12-29 Notax Holding Gesellschaft Mbh Verwendung von nonoxynol-9 als gleitmittel sowie verfahren zu seiner herstellung
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
RU2310474C2 (ru) 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
RU2274442C2 (ru) 2000-03-07 2006-04-20 Раш-Презбитериан-Ст. Лук'С Медикал Сентер Композиции и способы улавливания и инактивации патогенных микроорганизмов и сперматозоидов
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
NZ549469A (en) * 2001-02-15 2009-02-28 Access Pharma Inc Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
MXPA05008364A (es) 2003-02-07 2005-11-04 Janssen Pharmaceutica Nv Derivados de pirimidina para la prevencion de una infeccion por vih.
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
AP2014008149A0 (en) * 2012-06-13 2014-12-31 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
RU2691950C1 (ru) 2013-12-19 2019-06-19 Ивофем, Инк. Композиции и способы ингибирования воспаления и заболеваний с применением антимикробного соединения на основе альгиновой кислоты
CA2897038C (en) * 2014-07-14 2016-10-04 Novicol International Holding Inc. Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof
AU2017338748A1 (en) 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (es) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
DK0431719T3 (da) * 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Lab Inc Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
DK0500807T3 (da) * 1989-10-31 2000-02-07 Columbia Lab Inc Præparat og fremgangsmåde til befugtning af væv
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Also Published As

Publication number Publication date
ES2173203T3 (es) 2002-10-16
DE69525634D1 (de) 2002-04-04
US20010006667A1 (en) 2001-07-05
DE69525634T2 (de) 2002-08-29
JPH10507178A (ja) 1998-07-14
BR9509280A (pt) 1997-11-18
ATE213623T1 (de) 2002-03-15
FI971440A0 (fi) 1997-04-07
ZA958434B (en) 1996-05-08
KR970705976A (ko) 1997-11-03
WO1996010989A1 (en) 1996-04-18
EP0784466A1 (en) 1997-07-23
MX9504245A (es) 1997-01-31
PE46996A1 (es) 1996-11-23
DK0784466T3 (da) 2002-04-22
NO971491L (no) 1997-06-09
CA2201872A1 (en) 1996-04-18
HUT77527A (hu) 1998-05-28
AU704836B2 (en) 1999-05-06
FI971440A (fi) 1997-04-07
US5667492A (en) 1997-09-16
CO4480018A1 (es) 1997-07-09
MA23687A1 (fr) 1996-07-01
NO971491D0 (no) 1997-04-02
EP0784466B1 (en) 2002-02-27
NZ295947A (en) 1999-02-25
PT784466E (pt) 2002-06-28
RU2157184C2 (ru) 2000-10-10
AU3961295A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
IL115495A0 (en) Use and composition of an anti-sexually transmitted disease formulation
US5071644A (en) Topical drug delivery with thermo-irreversible gels
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
CA2111932A1 (en) Quick-Drying Gel-Type Disinfectant for Hands and Fingers
ES2077971T3 (es) Formulaciones medicinales en aerosol.
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
MY121743A (en) Progestin therapy with controlled bleeding
HK1008298A1 (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor.
IL114193A0 (en) Ophthalmic pharmaceutical compositions
ES2105332T3 (es) Polimeros quelantes.
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
ATE239431T1 (de) Abgabesystem bestehend aus einem vaginaschwamm
IL112269A0 (en) Polymer blend and its use for transdermal drug delivery
KR940005290A (ko) 생점착성 치료 조성물 및 사용방법
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
FI951266A (fi) Pieneliöitä tappavat detergentti-jodi-koostumukset, joilla on alentunut detergenttipitoisuus
MXPA04003976A (es) Agentes antiarritmicos de administracion vaginal para tratamiento de dolor pelvico e infertilidad.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
JPS5759805A (en) Tape pharmaceutical preparation
SE9302203D0 (sv) Composition for ophthalmic use
IT1254707B (it) Uso topico della calcitonima per la preparazione di medicamenti nella cataratta idiopatica senile e una composizione farmaceutica che la contiene
MX9703784A (es) Composiciones germicidas de detergente-yodo que incluyen polivinilpirrolidona y formadores de complejos surfactantes, no ionicos, compatibles.